Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir (ATAGLU)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2014 by University of Roma La Sapienza.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Giancarlo Ceccarelli, University of Roma La Sapienza Identifier:
First received: March 28, 2014
Last updated: NA
Last verified: March 2014
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)